-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UDxzZ9C9uKXyqw1zGPaDb3JG6vqwKPydFO540amZ4818OVUOdW/FXdzZfcMTbATI aVB+aOuEzj3ppwjD1dIVvA== 0000064670-06-000071.txt : 20061101 0000064670-06-000071.hdr.sgml : 20061101 20061101181656 ACCESSION NUMBER: 0000064670-06-000071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061030 FILED AS OF DATE: 20061101 DATE AS OF CHANGE: 20061101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDTRONIC INC CENTRAL INDEX KEY: 0000064670 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 410793183 STATE OF INCORPORATION: MN FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 710 MEDTRONIC PKWY STREET 2: MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 BUSINESS PHONE: 7635144000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GUEZURAGA ROBERT M CENTRAL INDEX KEY: 0001145150 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07707 FILM NUMBER: 061180172 BUSINESS ADDRESS: BUSINESS PHONE: 7635144000 MAIL ADDRESS: STREET 1: MEDTRONIC INC STREET 2: 710 MEDTRONIC PKWY, MS LC310 CITY: MINNEAPOLIS STATE: MN ZIP: 55432-5604 4 1 doc.xml PRIMARY DOCUMENT X0202 4 2006-10-30 0000064670 MEDTRONIC INC MDT 0001145150 GUEZURAGA ROBERT M MEDTRONIC, INC. 710 MEDTRONIC PARKWAY, M.S. LC310 MINNEAPOLIS MN 55432-5604 0 1 0 0 Sr VP & Pres, Diabetes Common Stock 2006-10-30 4 A 0 6161 0 A 45901.871 D Common Stock 421.656 I By 401(k) Plan Common Stock 1575.781 I By ESOP Stock Options (Right to buy) 48.7 2006-10-30 4 A 0 18481 0 A 2007-10-30 2016-10-30 Common Stock 18481 18481 D These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. This balance increased 334.296 due to exempt transactions including ESPP, dividend reinvestment, and dividend equivalent credits. The restrictions on this restricted stock award shall lapse on the third anniversary of the grant date if the Company's cumulative earnings growth during the three year period ending on the last day of fiscal year 2009 equals or exceeds a 9% compound annual growth rate, as determined by the Compensation Committee. In the circumstances of death, Disability or Retirement, these restrictions shall lapse on a pro-rata basis, provided that the mimimum threshhold has been achieved through fiscal 2009. Keyna P. Skeffington, Attorney-in-fact 2006-11-01 -----END PRIVACY-ENHANCED MESSAGE-----